ClinicalTrials.Veeva

Menu
H

HD Research LLC | First Surgical Hospital

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Acetaminophen
Ibuprofen
Bupivacaine Hydrochloride
Bupivacaine
HTX-011
VX-548
Bupivacaine HCl
CNTX-4975-05
Celecoxib
epinephrine

Parent organization

This site is a part of HD Research LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 21 total trials

A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease (VIVID-2)

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

Enrolling
Crohn's Disease
Drug: Mirikizumab

This is a Phase 4, randomized, blinded, active-controlled, multicohort study to evaluate HTX-011 compared with bupivacaine HCl in subjects undergoing...

Active, not recruiting
Analgesia
Drug: HTX-011
Drug: Acetaminophen

This Phase 2 open-label trial investigates the pharmacokinetics (PK), pharmacodynamics, and safety profile of TLC590 across various surgical procedur...

Enrolling
Postsurgical Pain Management
Drug: Ropivacaine
Drug: TLC590

This study will evaluate the safety, efficacy, and PK of low dose (750 mg) and high-dose (1250 mg) XG005 oral tablets compared with placebo in subjec...

Enrolling
Acute Pain
Drug: XG005 tablet
Drug: Placebo tablet

Trial sponsors

H
Pacira logo
C
Vertex Pharmaceuticals logo
C
I
Johnson & Johnson (J&J) logo
Lilly logo
T
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems